Amicus Therapeutics (FOLD) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Amicus Therapeutics (FOLD) over the last 14 years, with Q3 2025 value amounting to -$21.5 million.
- Amicus Therapeutics' Other Gross PP&E Adjustments rose 689.16% to -$21.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.5 million, marking a year-over-year increase of 689.16%. This contributed to the annual value of $35.9 million for FY2024, which is 1655.41% up from last year.
- Amicus Therapeutics' Other Gross PP&E Adjustments amounted to -$21.5 million in Q3 2025, which was up 689.16% from -$22.0 million recorded in Q2 2025.
- In the past 5 years, Amicus Therapeutics' Other Gross PP&E Adjustments registered a high of $41.8 million during Q4 2021, and its lowest value of -$32.0 million during Q3 2023.
- Its 5-year average for Other Gross PP&E Adjustments is -$13.1 million, with a median of -$22.4 million in 2021.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first soared by 3119.29% in 2021, then crashed by 4370.93% in 2022.
- Amicus Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $41.8 million in 2021, then plummeted by 43.71% to $23.5 million in 2022, then surged by 30.86% to $30.8 million in 2023, then increased by 16.55% to $35.9 million in 2024, then plummeted by 160.06% to -$21.5 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$21.5 million for Q3 2025, versus -$22.0 million for Q2 2025 and -$22.1 million for Q1 2025.